Deutsche Bank Upgrades Agilon Health to Buy, Raises Price Target to $49

Benzinga Newsdesk www.benzinga.com Positive 75.1%

Neg 0% Neu 0% Pos 75.1%

Deutsche Bank analyst George Hill upgrades Agilon Health (NYSE:AGL) from Hold to Buy and raises the price target from $33 to $49.